Ran Cao

2.0k total citations · 1 hit paper
54 papers, 1.3k citations indexed

About

Ran Cao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ran Cao has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ran Cao's work include PARP inhibition in cancer therapy (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Ran Cao is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Ran Cao collaborates with scholars based in China, United Kingdom and United States. Ran Cao's co-authors include Weiguo Jiang, Lihua Yuan, Wenming Shen, Wenjie Wang, Yunfei Zhang, Niu Huang, Bailing Xu, Ming Ji, Jie Zhou and Yanli Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Ran Cao

49 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatio-temporal analysis of vegetation variation in the Yellow River Basin

2014 420 citations Ran Cao et al. profile →

Peers

Countries citing papers authored by Ran Cao

Since Specialization

Citations

This map shows the geographic impact of Ran Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Cao more than expected).

Fields of papers citing papers by Ran Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Cao. The network helps show where Ran Cao may publish in the future.

Co-authorship network of co-authors of Ran Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Cao. A scholar is included among the top collaborators of Ran Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Cao. Ran Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Myricetin and 2-amino-3-methyl-3H-imidazole [4, 5-F] quinoline triggers liver injury by regulating gut microbiota and liver metabolism 2025 ·Journal of Hazardous Materials ·(unknown), Yanan Zhao, Ran Cao, (unknown), (unknown), Chang Zhang, (unknown), Lei Chen	0
2	Alleviation Effect of the Secondary Metabolite of Anthocyanin (Protocatechuic Acid) on Heterocyclic Amine (IQ)-Induced Liver Injury and Its Underlying Mechanism 2025 ·Journal of Agricultural and Food Chemistry ·Jiang Liu, Yanan Zhao, (unknown), (unknown), Ran Cao, (unknown), (unknown), Lei Chen	1
3	3D keypoint detection-based automated rebar spacing inspection: Application for robotic integration 2025 ·Advanced Engineering Informatics ·Lu Deng, (unknown), Jingjing Guo, Ran Cao, (unknown)	2
4	Fully Automated Online Adaptive Radiotherapy Decision Making for Cervical Cancer Using Artificial Intelligence 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Shanshan Sun, Ying Liang, Skye Hung‐Chun Cheng, Ran Cao, Shan He, Yang Bai, (unknown), Ke Hu, Fuquan Zhang	0
5	Tidal influence on residual saltwater removal behind subsurface dams in unconfined coastal aquifers 2024 ·Journal of Hydrology ·Tianyuan Zheng, Ran Cao, Yunhai Fang, Jian Luo, Peihua Li, Xilai Zheng, Xiuyu Liang, Tao Liu, Marc Walther	0
6	Leveraging Deep Spatiotemporal Sequence Prediction Network with Self-Attention for Ground-Based Cloud Dynamics Forecasting 2024 ·Remote Sensing ·(unknown), Min Wang, (unknown), Jiafeng Wang, Ran Cao	1
7	Price discrimination in mobile gacha games: A comprehensive study of the scarcity–pricing, gachaing–user profiling, and recharging–profiting models 2024 ·Managerial and Decision Economics ·Ran Cao, (unknown), Fangyuan Sun	1
8	Nanoparticle exsolutionviaelectrochemical switching in perovskite fibers for solid oxide fuel cell electrodes 2023 ·Journal of Materials Chemistry A ·Min Xu, Ran Cao, Shitao Wu, Jin Goo Lee, Di Chen, John T. S. Irvine	19
9	Complete Shift in Glycosyl Donor Specificity in Mammalian, but not C. elegans β1,4‐GalT1 Y286L mutants, Enables the Synthesis of N,N‐Diacetyllactosamine 2022 ·ChemCatChem ·Ran Cao, (unknown), Huan Chen, (unknown), (unknown), Kun Huang, (unknown), Sabine L. Flitsch, Li Liu, Josef Voglmeir	2
10	Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing 3-Substituted Piperizines as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis 2021 ·Journal of Medicinal Chemistry ·Jie Zhou, Ming Ji, Xiaoyu Wang, Hailong Zhao, Ran Cao, Jing Jin, Yan Li, Xianhong Chen, Sheng Li, Xiaoguang Chen, Bailing Xu	20
11	Development and Validation of a Nomogram for Preoperative Prediction of Lymph Node Metastasis in Lung Adenocarcinoma Based on Radiomics Signature and Deep Learning Signature 2021 ·Frontiers in Oncology ·Ran Jia, Ran Cao, (unknown), Tao Yu, Dan Zhao, Zhongliang Wang	27
12	Clinical and molecular characteristics of Chinese non‐small cell lung cancer patients with ERBB2 transmembrane domain mutations 2020 ·Molecular Oncology ·Yun Fan, Jinrong Qiu, Ruoying Yu, Ran Cao, Xiaoxi Chen, Qiuxiang Ou, Xue Wu, Yang Shao, Misako Nagasaka, Jiexia Zhang, Sai‐Hong Ignatius Ou	3
13	Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), Jing Jin, Hualong Chen, Ran Cao, Xiaoguang Chen, Bailing Xu	25
14	Mixed Lineage Kinase Domain-like Protein MLKL Breaks Down Myelin following Nerve Injury 2018 ·Molecular Cell ·Zhengxin Ying, (unknown), (unknown), Liqing Liu, Lin Li, (unknown), (unknown), Tianyi Yuan, Ran Cao, Zhaodi Jiang, She Chen, Fengchao Wang, Xiaodong Wang	68
15	In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery 2017 ·Journal of Medicinal Chemistry ·Yanli Wang, (unknown), Ran Cao, Dan Liu, Yuting Xie, Li Li, Xiangbing Qi, Niu Huang	24
16	Discovery of 2-substituted 1 H -benzo[ d ]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity 2017 ·European Journal of Medicinal Chemistry ·Jie Zhou, Ming Ji, Zhixiang Zhu, Ran Cao, Xiaoguang Chen, Bailing Xu	35
17	Free energy calculation provides insight into the action mechanism of selective PARP-1 inhibitor 2016 ·Journal of Molecular Modeling ·Ran Cao	4
18	Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors 2015 ·Bioorganic & Medicinal Chemistry ·(unknown), Ming Ji, Zhixiang Zhu, Jie Zhou, Ran Cao, Xiaoguang Chen, Bailing Xu	38
19	Combined 3D‐QSAR Modeling and Molecular Docking Study on Quinoline Derivatives as Inhibitors of P‐selectin 2009 ·Chemical Biology & Drug Design ·Huahui Zeng, Ran Cao, Huabei Zhang	8
20	Non-Nucleoside Inhibitors of NS5B Polymerase Binding to Allosteric Sites: 3DQSAR and Molecular Docking Studies 2008 ·Current Medicinal Chemistry ·Hongyu Cao, Ran Cao, Huabei Zhang, Xuefang Zheng, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact